Skip to content
TrialScanner

NCT05307705

A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors

Phase 1Active, not recruitingLLYLead

Registry record

Lead sponsor
Eli Lilly and Company
Conditions
Breast Cancer
Primary completion
Apr 2, 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05307705 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.